Brief: Hookipa Pharma Announces Positive Clinical Data To Be Presented At The American Society For Clinical Oncology 2024 Annual Meeting
23/05/2024 23:52
May 23 (Reuters) - HOOKIPA Pharma Inc HOOK.O :
* HOOKIPA PHARMA ANNOUNCES POSITIVE CLINICAL DATA TO BE
PRESENTED
AT THE AMERICAN SOCIETY FOR CLINICAL ONCOLOGY 2024 ANNUAL
MEETING
* HOOKIPA PHARMA INC: UPDATED DATA OF HB-200 PLUS
PEMBROLIZUMAB
DEMONSTRATE A FAVORABLE SAFETY PROFILE AND PROMISING CLINICAL
ACTIVITY
Source text for Eikon: ID:nGNX4JrHWG
Further company coverage: HOOK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hookipa Pharma
See all newsBrief: Hookipa Pharma Announces Sale Of Oncology Assets To Neotrail Therapeutics
Brief: Hookipa Pharma Announces Intention To Voluntarily Delist And Deregister Its Common Stock
Hookipa Pharma Inc Expected To Post A Loss Of $1.04 A Share: Earnings Preview
Brief: Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)